Clinical trial
A Multi-center, Randomized, Double-blind, Placebo-controlled, 12-week Phase II Study to Evaluate the Safety, Tolerability, Efficacy and Population PK of HMS5552 in Type 2 Diabetic Adult Subjects
NCT02561338 is registered in ClinicalTrials.gov with Hua Medicine Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blind, Placebo-controlled, 12-week Phase II Study to Evaluate the Safety, Tolerability, Efficacy and Population PK of HMS5552 in Type 2 Diabetic Adult Subjects
- Lead sponsor
- Hua Medicine Limited
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- September 30, 2016
- Enrollment
- 258 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.